greenleaf123/iStock via Getty Images A federal judge in Texas on Monday tossed a lawsuit filed by a leading drug industry…
Read More »NYSEMRK
Merck (NYSE:MRK) is reportedly in advanced talks to buy immuno-oncology company Harpoon Therapeutics (NASDAQ:HARP) for around $700M. Citing people familiar…
Read More »